Select Committee on Health Minutes of Evidence


Examination of Witnesses (Questions 620 - 639)

WEDNESDAY 28 JUNE 2006

MR KEN ANDERSON, MR BLEDDYN REES AND MR GEOFF SEARLE

  Q620  Mike Penning: What lessons did the Department learn from Phase 1 of the ISTC programme? How have these been applied in phase 2?

  Mr Anderson: We learned and we are applying them now. It is actually reference to the schemes we have looked at and decided not to go forward with. We need to firm up local delivery plans with the local health economies before we go out and start talking to private sector partners. We are now in the process of having detailed discussions with the folks on the ground. We are applying, I think, the lessons learned very well indeed around that process. The result of that were the seven schemes that you saw listed in the Health Service Journal.

  Q621  Mike Penning: The Secretary of State referred to the seven schemes being cancelled but the strategic health authorities affected in their own area have been told to provide more independent sector services to NHS patients. Can you explain how that is going to work if the ISTCs have been cancelled?

  Mr Anderson: I think it is an unfortunate misnomer, quite frankly. When we say cancelled, we should say cancelled in their present form.

  Q622  Mike Penning: The word "cancelled" means it is not going to happen: you have started and you have stopped.

  Mr Anderson: In their present form. I guess it would be applied to the present form, so we go back to the health economy and then we continue the conversation around what their needs are. But they have gone out and they have identified a gap or a necessity for extra throughput within that economy that would be provided by the private sector, and so, once you get down to nuts and bolts and you start talking about case mixes and the number of patients, and very honestly how maybe some of that will impact other local providers economically, then, until you can delve into the detail, it is very hard to get a true picture in that economy. The LDPs are a very macro look at what a health economy needs over the next given year, so, when you sit down and you start having discussions with the health economy, the package may not stack up in the same way that it was originally envisaged. We had the same issues, if you want to call it that—and I think it is a good discussion to have with the local economy—around how they stacked up, and we cancelled schemes in wave 1 which came back to health economy but in a different guise with a different case mix. Maybe, instead of being a stand-alone scheme, it then became something that we did on a JV basis with another National Health Service trust, or maybe it was a completely different package, where it was attached to a more community-based provision package. Until you can sit down and describe specifically what the private sector components are in their capabilities and have a detailed discussion, we cannot take it forward around the constraints of value for money—which we are going to talk about after this.

  Q623  Mike Penning: I think I will stop you at that point because I think you have used so much jargon I do not believe you have answered the question in the first place. We will come back to that.

  Mr Anderson: Okay.

  Q624  Dr Naysmith: The Secretary of State also wrote in her submission "we remain committed to investing £550 million on the procurement in the independent sector: this includes £50 million from the first wave of ISTCs." Is this £550 million per   annum over a five-year programme, which represents a total of £2.75 billion?

  Mr Anderson: Yes, that is £550 million annually.

  Q625  Dr Naysmith: If so, can you explain how this relates to PEQ (public expenditure questionnaire) from 2005, which suggests expenditure of up to £5.8  billion over Phases 1 and 2 of the ISTC programme.

  Mr Anderson: I am sorry, I do not have that in front of me. I could go back and look at that. I am not familiar with that figure.

  Q626  Dr Naysmith: Which one are you not familiar with, the £2.75 billion or the £5.8 billion?

  Mr Anderson: I think I would recognise £5.8 billion as a total between the Phase 1 and the Phase 2 combined procurements but I would not recognise that figure attached to the Phase 2 alone.

  Q627  Dr Naysmith: Phase 1 of 2.

  Mr Anderson: That is correct.

  Q628  Dr Naysmith: £5.8 billion is an accurate estimate, is it?

  Mr Anderson: I would imagine, roughly, with Phase 1 and 2 combined, you would probably get fairly close to that.

  Q629  Dr Naysmith: We were told that ISTC programmes were "consultative and pragmatic" and that schemes had been cancelled if it was clear that the local NHS had adequate capacity and also that the Government is "committed to investing £550 million on the procurement in the independent sector". How can you be sure that you meet that target and at the same time be committed to a number that is flexible and pragmatic.

  Mr Anderson: I think the flexible and pragmatic piece is being realised through the fact that we have dialogue with the local health economy and, in some cases, if the health economy has come to the conclusion, based on some of the assumptions they had made in the local delivery plan exercise, that that amount of activity is no longer needed then we talk to other health economies. Across England I do not think there is a lack of need for extra capacity, particularly around some of the elective procedural pieces that we are doing.

  Q630  Dr Naysmith: Will new ISTCs go ahead in any areas where it is clearly demonstrated there is no need for additional capacity? Is that what you are saying—although we have this figure of £550 million—if the demonstration is that ISTCs are not needed?

  Mr Anderson: If they demonstrate not a need for ISTCs, then that is a conversation they will have to have with ministers. As far as I know, we are not forcing ISTCs down anybody's throat, to add extra capacity in an area where they say specifically and categorically they do not need it.

  Q631  Mike Penning: We had evidence on Thursday's session from the Chief Executive of West Herts Hospital Trust, who clearly said to this Committee that they do not want the ISTC. It will have a major effect on them. They will physically have to knock down a hospital which is perfectly okay: five theatres working very well. Are you saying that, if that trust does not want that ISTC, they go to the Minister and the Minister would listen?

  Mr Anderson: We have a conversation with the trust initially. We are still having conversations with Hertfordshire as we speak. That scheme was one that started in the Phase 1 portion of the schemes, and one of the reasons it has not gone forward to date is because we are still talking to that health economy about their needs.

  Q632  Mike Penning: That you have not progressed because there is an argument over the need.

  Mr Anderson: No. I would not characterise it as an argument. I would characterise it as a discussion. The flip side of that is that health economies used the independent sector treatment centre programme as a reconfiguration tool as well. There is capacity in the NHS that we pay for that is not necessarily applicable to today's type of health care. Those are very detailed conversations around an extremely sensitive and extremely involved strategic issue for health economies. It is not something that you can resolve in a matter of days or weeks even and it takes a detailed conversation with the health economy around what does reconfiguration look like and what does 21st century healthcare look like.

  Q633  Mike Penning: If West Herts Hospital Trust want to reconfigure, and you are aware of the situation . . . Reconfigure, by the way, means knocking down a general hospital because that is what is going to happen.

  Mr Anderson: Not necessarily. I would not accept that.

  Q634  Mike Penning: The only way that can go ahead is if the ISTC comes in. It is a tool.

  Mr Anderson: It is not the only way. There are a lot of health economies who are reconfiguring without ISTCs or independent sector involvement. It depends on what tool that health economy needs.

  Q635  Mike Penning: I am interested in your comment that if they are not happy they go to the Minister—and the Minister says, "It is nothing to do with me," and passes it down the line.

  Mr Anderson: No, that was not what I meant at all.

  Mike Penning: That is what happens in real life.

  Q636  Dr Naysmith: Following on that line, the Minister also said, when we were discussing the decision not to go ahead with seven of the Phase 2 schemes, that "in other [areas] it has become clear that the level of capacity required by the local NHS does not justify new ISTC schemes"—which is really what we are discussing now. You ought to be able to provide us with a list of those areas where you have been looking at the possibility of going ahead.

  Mr Anderson: I think we can give you a note on that. I do not have that detailed information in front of me.[1]


  Q637  Chairman: Presumably it would not be much different from the seven that are highlighted in the Health Service Journal.

  Mr Anderson: I think it might reflect the Health Service Journal article.

  Q638  Chairman: You think it is pretty accurate, do you?

  Mr Anderson: I think they had reasonable information, and they tend to . . . I do not know the complete content of the Health Service Journal. I do know the seven schemes that they were talking about. The article was accurate to the point of the seven schemes that we have decided to look at differently, or to go some place else and try to draw that value out of a different area.

  Q639  Mike Penning: There are clearly other schemes that you are looking at on top of that seven.

  Mr Anderson: If there are not in ITN, yes.


1   See Ev 218 Volume III Back


 
previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2006
Prepared 25 July 2006